-
High-Performance Novel HAT Cell Line for Gene Therapy, Published in Molecular Therapy Methods & Clinical Development, and Ready for Commercial Use
-
Media / Editorial
2025.11.24
CHITOSE’s Resource Circulation Business Featured in Forbes Japan and The Chemical Daily
-
CHITOSE’s AI Doubles Protein Productivity in Filamentous Fungi Compared to Best Human-Designed Conditions
